Barlow Syndrome Companies

Global Barlow's Syndrome Market Overview

Barlow’s Syndrome Market  is expected to grow USD 750 Million at a CAGR 8.60% during the forcast period 2023 to 2030.Barlow’s syndrome is an abnormality of the mitral valve of the heart. It is a condition in which the leaflets of the mitral valve swell and shifts towards to the left atrium of the heart as the valve closes during ventricular contraction. This abnormality prevents the valve from closing suitably, which causes it to leak.

Barlow’s Syndrome can be caused by various reasons, some of them are calcium buildup, congenital heart defects, radiation treatment, and tumors. Additionally, traumatic injury, disease, or infection can lead to Barlow’s Syndrome.

The Barlow’s Syndrome market is estimated to lead a healthy growth. The Barlow’s Syndrome market is majorly driven by increasing geriatric population, rising global population, and rising cardiovascular disorders. According to a report published by the U.S. Population Reference Bureau, nearly 46 million people aged 65 years or more in 2014, and the report estimates that this number would double to reach nearly 98 million people by the end of 2060. Similarly, the 65-and-older age group would reach  up to nearly 24% by 2030 from 15% as of 2015.

Barlow’s Syndrome market is expected to grow at a CAGR of 8.60% during the forecast period.

Figure: Global Barlow’s Syndrome market, by region, 2017 (%)

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, market research future analysis, annual report, white paper, company presentation

 Intended Audience

• Pharmaceutical Manufacturers and Suppliers


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors

Barlow's Syndrome Market Segment Insights 

Barlow's Syndrome Type Insights

The Barlow’s Syndrome market is segmented as mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation.

Barlow's Syndrome Treatment Insights

The Barlow’s Syndrome market is segmented into medications and surgery. The medications are further sub-segmented into beta-blockers and calcium blockers. Beta-blockers further sub-segmented into Atenolol and Metoprolol. Calcium blockers further sub-segmented into Verapamil and Diltiazem.  

Barlow's Syndrome Diagnosis Insights

The Barlow’s Syndrome market is segmented into X-ray, Electrocardiogram, and Echocardiogram.

Barlow's Syndrome End User Insights

The Barlow’s Syndrome market is segmented into hospitals & surgical centers, research institutes, and specialty clinics.

Barlow's Syndrome Regional Insights

North America holds the maximum share of the Barlow’s Syndrome market in the Americas region. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. Increasing geriatric population, rising number of cardiovascular disorders, and growing population have increased the scope of the Barlow’s Syndrome   market in the North American market.

Europe holds  the second largest share of the Barlow’s Syndrome market. The European market is expected to grow at a healthy growth during the forecasted period. Various Factors such as availability of advanced treatment facilities, increasing cardiovascular diseases, and skilled medical professionals  are propelling the growth of Barlow’s Syndrome  market in the European region. For instance, according to the European Heart Network, cardiovascular disorders accounted for 45% of the total deaths in 2015. Additionally, increasing government healthcare initiatives and growing research and development activities supported by the government to provide better healthcare treatments are likely to boost the market growth.  

The Asia Pacific is expected to be the fastest growing Barlow’s Syndrome market owing to increasing incidence of chronic diseases, and fetal disorders. India is the fastest growing region owing to increasing population and increasing geriatric population. Rising awareness, growing standard of living, and availability of new treatment methods are likely to drive the market growth in this region.

The Middle East & Africa is expected to show steady growth in the Barlow’s Syndrome market . Major factors that are affecting the growth are lack of awareness, and  limited access and availability of treatment facilities. In the Middle East, United Arab Emirates  has accounted for the largest market share owing to the development of healthcare infrastructure, skilled healthcare providers.

Key Players